Table 4.
Characteristics of PCC/PGL patients
| Characteristics | Total Group | Incidentaloma Group | Symptomatic Group | Genetic Group | Other |
|---|---|---|---|---|---|
| Age | 54.5 (28-83) y | 59.84 (± 11.9) y | 49.74 (±xx 15.6) y | 40.92 (15-51) y | |
| Number of patients | 86 | 51 (59.3%) | 25 (29.06%) | 10 (11.6%) | |
| F/M | 45/41 | 22/29 | 15/8 | 7/5 | |
| Symptoms Headaches Palpitations Sweating Paroxysmal Symp Classic triad BP systolic BP diastolic |
38/86 44.2% 40/86 46.5% 38/86 44.2% 21/86 24.4% 27/86 31.34% |
12/51 23.5% 14/51 27.5% 12/51 23.5% 2/51 3.92% 6/51 11.8% |
23/23 100% 20/23 86.9% 22/23 95.6% 18/23 78.3% 19/23 82.6% SG>IG p-0.002 SG>IG p- 0.001 |
2/12 16.67% 6/12 50% 5/12 41.67% 3/12 25% 2/12 16.67% GG>SG p-0.0036 |
SG>IG>GG SG>GG>IG0.0001 SG>GG>IG0.0001 SG>GG>IG0.0001 SG>GG>IG0.0001 |
| Tumour size | IG=GG | SG>IG p-0.0169 | GG=SG | Kruskal-Wallis test | |
| Hormone level ratio | IG=GG | SG>IG p-0.0019 | GG=SG | Kruskal-Wallis test | |
| Inotropes | IG=SG=GG p-0.29 | Chi-square test | |||
| Postop complications | IG=SG=GG | Crosstab | |||
| Days in HDU/ICU Length of hospital stay |
IG=SG=GG p-0.10 IG=SG=GG p0.27 |
Kruskal-Wallis test Kruskal-Wallis test |
|||
| Paroxysmal symptoms vs. age | Younger if with symp p-0.0087 | No p-0.52 | No p-0.6 | No p-0.89 | Student test |
| Classic triad vs. age | Younger if with symp p-0.0004 | Yes, younger if with symp p-0.038 | No p-0.11 | No p-0.49 | Student test |
| Gender vs. paroxysmal symptoms | F>M p-0.011 | No p>0.05 | No p>0.05 | No p>0.05 | Crosstab |
| Gender vs. classic triad | F>M p-0.052 | No p>0.05 | No p>0.05 | No p>0.05 | chi-square test |
| Paroxysmal symptoms vs. preop hormone ratio | Yes with p-0.0048 | No no p possible | No p-0.779 | No p-0.0074 | Man Whitney test |
| Headaches vs. preop hormone ratio | Yes with p-0.00479 | No p-0.24 | No p value possible | No p-0.68 | Man Whitney test |
| Sweating vs. preop hormone ratio | Yes with p-0.0025 | No p-0.36 | No p-0.21 | No p-0.25 | Man Whitney test |
| Palpitations vs. preop hormone ratio | No p-0.27 | No p-0.61 | Yes p-0.033 | No p-0.67 | Man Whitney test |
| Gender vs. BP(sys/dias) | No p-0.93 | No p-0.19 | No p-0.67 | No p-0.078 | Student test |
| Gender vs. tumour size | No p-0.45 | Man Whitney test | |||
| Classic triad vs. tumour size | No p-0.15 | No p-0.42 | No p-0.32 | No p-0.95 | Man Whitney test |
| Tumour size vs. BP | No p>0.005 | Spearman test | |||
| Gender vs. preop hormone ratio | No p-0.19 | No p-0.23 | No p-0.87 | ||
| Classic triad vs. preop hormone ratio | No p-0.635 | No p-0.62 | Yes with p-0.0086 | No p-0.95 | Man Whitney test |
| Tumour size vs. inotropes | No p-0.82 | No | No | No | Kruskal Wallis and Dunns test |
| BP vs. inotropes Sys Dias |
No p-0.12 No p-0.33 |
No | No | Yes higher Yes higher |
Kruskal Wallis and Dunns test |
| Paroxysmal symp vs. inotropes | Yes more ino with p-0.014 | Yes more ino with p-0.049 | No p-0.41 | Yes more ino with p-0.02 | chi square test |
| Tumour size vs. postop complications | No p-0.64 | No p-0.688 | No p-0.192 | No p-0.108 | Mann Whitney test |